Ruxolitinib cream for treating moderate atopic dermatitis after topical corticosteroids and calcineurin inhibitors ID6602Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 3 June 2027
Rocatinlimab for treating moderate to severe atopic dermatitis in people 12 years and over [ID6565]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Topical tapinarof for treating atopic dermatitis in people 2 years and over ID6713Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC